27940059|t|Use of the levonorgestrel 52-mg intrauterine system in adolescent and young adult solid organ transplant recipients: a case series
27940059|a|This case series reports on the safety and efficacy of the levonorgestrel 52-mg intrauterine system in adolescent and young adult solid organ transplant recipients. All patients used the device for contraception, with no documented cases of disseminated pelvic infection or unplanned pregnancy.
27940059	11	25	levonorgestrel	T109,T121,T125	C0023566
27940059	32	51	intrauterine system	T169	C1522228
27940059	55	65	adolescent	T100	C0205653
27940059	70	81	young adult	T100	C0238598
27940059	82	104	solid organ transplant	T061	C0730400
27940059	105	115	recipients	T101	C0376387
27940059	119	130	case series	T062	C0150093
27940059	136	147	case series	T062	C0150093
27940059	148	155	reports	T062,T170	C0242278
27940059	163	169	safety	T080	C0678800
27940059	174	182	efficacy	T080	C0598333
27940059	190	204	levonorgestrel	T109,T121,T125	C0023566
27940059	211	230	intrauterine system	T169	C1522228
27940059	234	244	adolescent	T100	C0205653
27940059	249	260	young adult	T100	C0238598
27940059	261	283	solid organ transplant	T061	C0730400
27940059	284	294	recipients	T101	C0376387
27940059	300	308	patients	T101	C0030705
27940059	318	324	device	T074	C0009886
27940059	329	342	contraception	T061	C0700589
27940059	352	362	documented	T058	C1301725
27940059	372	384	disseminated	T082	C0205221
27940059	385	401	pelvic infection	T047	C0030790
27940059	405	424	unplanned pregnancy	T033	C0041747